Kathleen Smith

536 total citations
6 papers, 312 citations indexed

About

Kathleen Smith is a scholar working on Epidemiology, Cell Biology and Physiology. According to data from OpenAlex, Kathleen Smith has authored 6 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Epidemiology, 2 papers in Cell Biology and 2 papers in Physiology. Recurrent topics in Kathleen Smith's work include Nail Diseases and Treatments (3 papers), Plant Pathogens and Fungal Diseases (2 papers) and Fungal Infections and Studies (1 paper). Kathleen Smith is often cited by papers focused on Nail Diseases and Treatments (3 papers), Plant Pathogens and Fungal Diseases (2 papers) and Fungal Infections and Studies (1 paper). Kathleen Smith collaborates with scholars based in United States, Canada and Japan. Kathleen Smith's co-authors include Radhakrishnan Pillai, Boni E. Elewski, Richard Pollak, David M. Pariser, Hisato Senda, Jason T. Olin, Phoebe Rich, Shinichi Watanabe, Mark Lebwohl and Melinda Gooderham and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Academy of Dermatology and European Neuropsychopharmacology.

In The Last Decade

Kathleen Smith

6 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathleen Smith United States 6 196 139 63 54 46 6 312
Grace Allen United Kingdom 8 111 0.6× 9 0.1× 89 1.4× 32 0.6× 8 0.2× 18 248
Jeremiah Miller United States 6 56 0.3× 22 0.2× 166 2.6× 39 0.7× 50 1.1× 6 301
Yunliu Chen China 7 291 1.5× 11 0.1× 26 0.4× 33 0.6× 26 0.6× 19 398
Maggie Z. X. Xiao Canada 9 67 0.3× 21 0.2× 12 0.2× 48 0.9× 18 0.4× 22 252
Rosa Pettinato Italy 11 70 0.4× 15 0.1× 179 2.8× 48 0.9× 37 0.8× 20 512
Amal A Kokandi Saudi Arabia 6 15 0.1× 37 0.3× 125 2.0× 30 0.6× 12 0.3× 18 274
Alireza Heiran Iran 10 34 0.2× 43 0.3× 70 1.1× 9 0.2× 8 0.2× 40 252
Natalie Sun United States 9 47 0.2× 6 0.0× 46 0.7× 35 0.6× 88 1.9× 17 273
Erika Rigotti Italy 6 44 0.2× 14 0.1× 63 1.0× 15 0.3× 128 2.8× 18 314
Daliparthy D. Pratyush India 9 63 0.3× 7 0.1× 17 0.3× 20 0.4× 20 0.4× 11 339

Countries citing papers authored by Kathleen Smith

Since Specialization
Citations

This map shows the geographic impact of Kathleen Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen Smith more than expected).

Fields of papers citing papers by Kathleen Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen Smith. The network helps show where Kathleen Smith may publish in the future.

Co-authorship network of co-authors of Kathleen Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen Smith. A scholar is included among the top collaborators of Kathleen Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen Smith. Kathleen Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Lebwohl, Mark, Kim Papp, Linda Stein Gold, et al.. (2020). Trial of Roflumilast Cream for Chronic Plaque Psoriasis. New England Journal of Medicine. 383(3). 229–239. 67 indexed citations
2.
Sawyer, Taylor, et al.. (2015). Retention of Pediatric Resuscitation Performance After a Simulation-Based Mastery Learning Session. Pediatric Critical Care Medicine. 16(2). 131–138. 37 indexed citations
3.
Rosso, J.Q. Del, et al.. (2013). Efinaconazole 10% solution: a new topical treatment for onychomycosis: contact sensitization and skin irritation potential.. PubMed. 6(3). 20–4. 8 indexed citations
4.
Jarratt, Michael, et al.. (2013). Safety and pharmacokinetics of efinaconazole 10% solution in healthy volunteers and patients with severe onychomycosis.. PubMed. 12(9). 1010–6. 25 indexed citations
5.
Elewski, Boni E., Phoebe Rich, Richard Pollak, et al.. (2012). Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies. Journal of the American Academy of Dermatology. 68(4). 600–608. 167 indexed citations
6.
Mcconville, B.J., Lisa A. Arvanitis, Per T. Thyrum, & Kathleen Smith. (1999). Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine in adolescents with selected psychotic disorders. European Neuropsychopharmacology. 9. 267–267. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026